Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name "Vaishali Pharma Private Limited" on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company. Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 formulation brands marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Company`s synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients. In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments & Medical Devices Directive. In addition, the Company has also been recognized by Government of India as `One Star Export House` and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.

Vaishali Pharma share price as on 24 Mar 2025 is Rs. 12.36. Over the past 6 months, the Vaishali Pharma share price has decreased by 35.93% and in the last one year, it has decreased by 14.58%. The 52-week low for Vaishali Pharma share price was Rs. 11.65 and 52-week high was Rs. 24.91.

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name "Vaishali Pharma Private Limited" on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company. Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 formulation brands marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Company`s synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients. In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments & Medical Devices Directive. In addition, the Company has also been recognized by Government of India as `One Star Export House` and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.

Vaishali Pharma share price as on 24 Mar 2025 is Rs. 12.36. Over the past 6 months, the Vaishali Pharma share price has decreased by 35.93% and in the last one year, it has decreased by 14.58%. The 52-week low for Vaishali Pharma share price was Rs. 11.65 and 52-week high was Rs. 24.91.